Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-5204
Dr. Haddox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Candace Haddox, MD is an Oncologist based in Boston, MA, specializing in Sarcoma. She completed her medical degree at the University of South Florida College of Medicine in 2015, followed by an Internal Medicine residency at Mayo Clinic College of Medicine and Science. Dr. Haddox subsequently pursued a Hematology and Medical Oncology fellowship at Duke University Hospital. Currently, she is a Clinical Investigator at Dana-Farber Cancer Institute. Her areas of expertise include medical education, biomedical research, medical oncology, and clinical trials. Dr. Haddox has published several influential papers in Clinical Cancer Research, Cancer Discovery, CA, Expert Review of Anticancer Therapy, and Faculty Reviews.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2018 - 2021
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
University of South Florida College of MedicineClass of 2015
Certifications & Licensure
NH State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
MA State Medical License 2021 - 2025
ME State Medical License 2022 - 2025
NC State Medical License 2018 - 2021
MN State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Leiomyosarcoma Therapeutic Approaches and Future Directions.Candace L Haddox, David J Papke Jr, César Serrano
Hematology/oncology Clinics of North America. 2025-08-01 - Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets.Michael J Wagner, Erica M Pimenta, Nathan W Sweeney, Elizabeth T Loggers, Jesse L Roberts
JCO Precision Oncology. 2025-03-01 - 2 citationsClinician's primer for soft tissue sarcomas: Nuances of histologic subtypes.Amy J Wisdom, Chandrajit P Raut, Candace L Haddox, Jason L Hornick, Jyothi P Jagannathan
Cancer. 2025-03-01
Journal Articles
- Submandibular parasympathetic gangliogenesis requires sprouty-dependent wnt signals from epithelial progenitors.Knosp WM, Knox SM, Lombaert IM, Haddox CL, Patel VN, Hoffman MP., Developmental Cell, 3/23/2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
